|
||||||
|
NexMed Announces First Patent Allowance for Vitaros® in Japan SAN DIEGO—-NexMed, Inc. , a specialty CRO with a pipeline of product candidates based on the NexACT® technology, today announced that the Japanese Patent Office has issued the Decision to Grant a Patent for NexMed’s patent application entitled, “Prostaglandin Compositions for the Treatment of Male Erectile [...] NexMed Announces Pre-Clinical Results Showing That Its Proprietary Calcipotriene Betamethasone Psoriasis Formulation … SAN DIEGO—-NexMed, Inc. , a specialty CRO with a pipeline of products based on the NexACT® technology, today announced results from a pre-clinical study showing that calcipotriene 0.005% and betamethasone dipropionate 0.064%, when formulated with NexACT®, results in a topical treatment which [...] |
 |
|||||
|
Copyright © 2012 PSORIASIS TREATMENT - All Rights Reserved |
||||||
Recent Comments